Network Immunology
Network Immunology is revolutionizing immunotherapy by rebalancing the immune system to treat allergies, autoimmune conditions, and chronic inflammation in humans and animals. Grounded in Nobel Prize-winning immune network theory, their platform AbstimX™ aims to reset and rebalance immune function, addressing root causes rather than masking symptoms. With a team of experts in medicine, veterinary therapeutics, biotech, and immunology, they are developing long-term therapies for both humans and companion animals, with a focus on scalable, science-driven solutions.
Industries
Nr. of Employees
small (1-50)
Network Immunology
Vancouver, British Columbia, Canada, North America
Patents
Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases
US-12090202-B2
View Details
Combination of plasma immunoglobulin and antigen-specific immunoglobulin for the modification of the immune system and the treatment or prevention of allergic diseases
US-12090202-B2
View DetailsProducts
Canine injectable therapy for allergies (veterinary)
A subcutaneous injectable immunotherapy candidate designed to reduce allergic hypersensitivity in dogs by rebalancing immune responses.
Canine injectable therapy for autoimmune disease (veterinary)
A veterinary subcutaneous injectable candidate intended to modulate autoimmune pathology in dogs through network-level immune modulation.
Canine injectable therapy for colitis and digestive inflammation (veterinary)
A veterinary subcutaneous injectable candidate targeting colitis and digestive inflammation via immune network modulation.
Human injectable therapy for allergies (development-stage)
A development-stage subcutaneous injectable immunotherapy intended to reduce human allergic disease by modulating immune network behavior.
Human injectable therapy for autoimmune conditions (development-stage)
A development-stage subcutaneous injectable candidate intended to treat human autoimmune diseases through network-level immune modulation.
Canine injectable therapy for allergies (veterinary)
A subcutaneous injectable immunotherapy candidate designed to reduce allergic hypersensitivity in dogs by rebalancing immune responses.
Canine injectable therapy for autoimmune disease (veterinary)
A veterinary subcutaneous injectable candidate intended to modulate autoimmune pathology in dogs through network-level immune modulation.
Canine injectable therapy for colitis and digestive inflammation (veterinary)
A veterinary subcutaneous injectable candidate targeting colitis and digestive inflammation via immune network modulation.
Human injectable therapy for allergies (development-stage)
A development-stage subcutaneous injectable immunotherapy intended to reduce human allergic disease by modulating immune network behavior.
Human injectable therapy for autoimmune conditions (development-stage)
A development-stage subcutaneous injectable candidate intended to treat human autoimmune diseases through network-level immune modulation.
Services
Collaborative preclinical and clinical research partnerships with academic institutions to conduct veterinary trials and advance translational programs.
Engagement with commercial partners and investors to license platform technologies and support market entry for veterinary and human therapeutics.
Provision of investor materials and fundraising activities to secure capital for clinical trials and commercialization.
Collaborative preclinical and clinical research partnerships with academic institutions to conduct veterinary trials and advance translational programs.
Engagement with commercial partners and investors to license platform technologies and support market entry for veterinary and human therapeutics.
Provision of investor materials and fundraising activities to secure capital for clinical trials and commercialization.
Expertise Areas
- Systems immunology and immune network theory
- Antibody-based therapeutic development
- Preclinical translational research
- Veterinary clinical development
Key Technologies
- Immune network theory (systems immunology)
- Antibody-based network therapies
- Subcutaneous injectable biologic formulations
- Animal model-based preclinical studies